Reaction mixed to Biohaven’s migraine drug results
March 27, 2018Manufacturing and Production, Research and Development Allergan, Biohaven, CGRP, biotech, drugs, migraine, pharma, pharmaceutical
Biohaven is full of confidence in its lead drug, rimegepant, evidenced only a few weeks ago when it decided to …
GSK to take control of Consumer Healthcare in £9.2bn buyout
March 27, 2018Manufacturing and Production, Sales and Marketing Consumer Health Care, GSK, Novartis, biotech, drugs, horlicks, pharma, pharmaceutical
GSK has announced that it plans to purchase Novartis’ 36.5% stake in the joint Consumer Healthcare Business for a sum …
The April 2018 issue of Pharmafocus is now live!
March 27, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Martin Shkreli, Right to try, atrial fibrillation, falsified medicines directive, oncology, opioids, pharma
As we finally pass into Spring after what still feels like a particularly stubborn Winter, we are pleased to announce …
Seattle Genetics gain breakthrough therapy designation
March 26, 2018Manufacturing and Production, Sales and Marketing Astellas, Seattle Genetics, biotech, drugs, pharma, pharmaceutical
Seattle Genetics and Astellas have confirmed that the drug candidate they are co-developing, enfortumab, has been given FDA breakthrough therapy …
Ablynx’s vobarilizumab trial fails and sees two patient deaths in systemic lupus erythematosus
March 26, 2018Research and Development, Sales and Marketing AbbVie, Ablynx, Sanofi, Vobarilizumab, pharma, systemic lupus erythematosus
Ablynx has revealed that its interleukin 6 pathway via its IL-6 receptor (IL-6R) vobarilizumab failed to meet its primary endpoint …
Six reasons why UK pharma has more to gain, than fear, from Brexit
March 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, biotech, brexit, drugs, hard Brexit, pharma, pharmaceutical
There are good reasons to think exiting the EU represents a major opportunity for this dynamic and world-leading industry, argues …
Takeda and TiGenix’s Alofisel becomes first donor-derived stem cell therapy approved in Europe
March 26, 2018Sales and Marketing Crohn’s disease, EU, Europe, European Commission, Takeda, TiGenix, crohn's disease, pharma
The European Commission has awarded approval to Takeda and TiGenix’s allogeneic expanded adipose-derived stem cell (eASC) therapy Alofisel (darvadstrocel) for …
May faces pressure for cross-party talks over NHS future
March 26, 2018Medical Communications, Sales and Marketing NHS, Theresa May, UK government, biotech, drugs, pharma, pharmaceutical
A group of close to 100 MPs have demanded that Theresa May set up a parliamentary commission to plot the …
GSK’s shingles vaccine secures EU and Japan approvals
March 26, 2018Sales and Marketing EU, Europe, GSK, Japan, Shingrix, pharma, shingles
GlaxoSmithKline has announced that its shingles vaccine Shingrix has secured approval in two new regions: in Europe, for the prevention …
Roche’s Tecentriq improves OS in first-line lung cancer
March 26, 2018Research and Development, Sales and Marketing Roche, biotech, drugs, lung cancer, pharma, pharmaceutical, tecentriq
Roche has revealed further data from its Phase 3, IMpower150 study, which showed that a combination of Tecentriq and Avastin, …
Top Ten most popular articles on Pharmafile.com this week
March 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma
As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …
Indivior rocked by loss of patent case
March 23, 2018Medical Communications, Sales and Marketing Alvogen, biotech, drugs, indivior, opioid, pharma, pharmaceutical
Indivior has been dealt a hammer blow after US District Court for the District of Delaware found in favour of …
Medical waste in India to hit 775.5 tonnes daily by 2022, study suggests
March 23, 2018Manufacturing and Production, Medical Communications India, medical waste, pharma
A new report has shed light on the worrying state of medicinal wastage in India, indicating that the levels of …
Lifestyle factors to blame for 38% of cancers
March 23, 2018Medical Communications Cancer, Cancer Research UK, UK government, biotech, drugs, pharma, pharmaceutical
A new study by Cancer Research UK has found that more than 135,500 cases of cancer every year in the …
GSK withdraws from running for Pfizer Consumer Health
March 23, 2018Medical Communications, Sales and Marketing GSK, Pfizer, Pfizer Consumer Health, biotech, drugs, pharma, pharmaceutical
GSK has announced that it has decided to pull out of the race to acquire Pfizer’s Consumer Health business, ending …
Promising drug for hormone therapy-resistant breast cancer enters human trials
March 22, 2018Research and Development TTC-352, breast cancer, chicago, pharma
A team of researchers at Chicago’s University of Illinois (UIC) have revealed that their promising drug which could prove an …
US “right to try” legislation passes after initial defeat
March 22, 2018Medical Communications, Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma
The controversial and much-discussed “right to try” bill has been passed in the US House of Representatives, quickly rebounding after …
Regeneron-Alnylam team up to treat NASH
March 22, 2018Research and Development, Sales and Marketing Alnylam, Regeneron, biotech, drugs, nash, pharma, pharmaceutical
Coming on the back of a Regeneron research piece published in the New England Journal of Medicine, the company announced …
Bayer-Monsanto deal one step closer, after EU nod
March 22, 2018Sales and Marketing Bayer, EU, biotech, drugs, monsanto, pharma, pharmaceutical
The merger between Bayer and agricultural giant, Monsanto, is inching closer to completion after the EU Commission won EU antitrust …
Sun Pharma receives approval for first biologic drug
March 22, 2018Sales and Marketing Sun Pharma, biotech, drugs, pharma, pharmaceutical
The beginning of Sun Pharma’s diversification out of generic drugs is here and it’s a drug that MSD, known as …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
